|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.09 EGP | +2.15% |
|
+5.75% | +13.26% |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
| 03-12 | GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.15% | +5.75% | -2.88% | +18.16% | +13.26% | +88.32% | +130.32% | +99.75% | +738.26% | 123M | |
| +2.96% | +3.01% | +9.20% | +32.70% | +14.97% | +59.87% | +173.31% | +423.94% | +1,457.69% | 1,102B | |
| +3.05% | +5.23% | +14.81% | +12.09% | +29.13% | +72.11% | +67.81% | +57.75% | +118.14% | 643B | |
| -0.04% | +1.20% | +12.07% | +23.39% | +11.45% | +35.72% | +87.93% | +118.12% | +301.47% | 450B | |
| -2.58% | -2.07% | +1.44% | +4.34% | +1.10% | +27.62% | +22.57% | -6.14% | +31.98% | 336B | |
| +1.36% | +0.17% | +8.06% | +5.84% | +15.69% | +29.90% | +49.33% | +49.23% | +58.40% | 288B | |
| +1.98% | +4.08% | +20.39% | +39.28% | +0.68% | -25.78% | -39.02% | +20.99% | +79.03% | 222B | |
| +0.45% | +1.65% | +5.30% | +8.26% | +12.46% | +25.65% | +68.35% | +51.34% | +135.07% | 199B | |
| +5.21% | +7.93% | +5.57% | -1.76% | +11.10% | +21.99% | +83.23% | +99.47% | +59.54% | 169B | |
| +1.48% | -0.04% | -7.57% | -11.18% | -3.33% | -4.64% | -32.25% | -38.83% | -32.71% | 137B | |
| -1.39% | +5.14% | +16.88% | +20.93% | +15.20% | +13.68% | +54.43% | +162.45% | +479.96% | 133B | |
| +2.24% | +0.61% | +1.22% | +0.52% | +7.47% | +24.69% | -7.47% | -13.66% | -21.75% | 118B | |
| +1.01% | +1.11% | +4.70% | -4.44% | +9.78% | +43.53% | +52.20% | +11.51% | -3.35% | 107B | |
| +1.70% | +0.93% | -2.78% | -5.88% | -8.39% | -8.08% | -19.34% | -12.70% | +2.35% | 104B | |
| -2.60% | -1.49% | -0.58% | -15.07% | -9.96% | +3.95% | +89.97% | +75.67% | +499.35% | 77.46B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -0.70% | +4.98% | +42.39% | +29.41% | +37.31% | +94.34% | +4.22% | -0.29% | -42.65% | 57.05B | |
| -2.48% | +4.59% | +17.59% | -1.81% | -7.07% | +3.94% | +15.07% | -10.80% | +265.50% | 53.81B | |
| +0.94% | +6.67% | +8.89% | -5.16% | +13.73% | +24.64% | +24.69% | +49.23% | +25.03% | 53.16B | |
| +1.92% | +5.09% | +10.39% | -1.03% | -2.51% | -1.59% | +18.33% | - | - | 43.09B | |
| Average | +0.51% | +2.66% | +8.69% | +7.82% | +8.53% | +27.89% | +44.40% | +63.17% | +230.63% | 217.76B | |
| Weighted average by Cap. | +1.25% | +2.00% | +9.37% | +15.81% | +12.58% | +38.32% | +77.02% | +146.78% | +472.67% |
- Stock Market
- Stocks
- BIOC Stock
- Sector GlaxoSmithKline S.A.E
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
